Electrical storm: Still a cryptogenic phenomenon?

European Heart Journal

Volumn 27, Issue 24, 2006, Pages 2921-2922

  Haverkamp, Wilhelm ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOFETILIDE; SOTALOL;

ACCURACY; CLINICAL TRIAL; DEFIBRILLATOR; DRUG SAFETY; EDITORIAL; ELECTROGRAPHY; ELECTROSTIMULATION; FOLLOW UP; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; INCIDENCE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; STATISTICAL ANALYSIS; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TACHYCARDIA, VENTRICULAR;

EID: 33845610227     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl396     Document Type: Editorial

References (10)

1. Sears SF, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003;26:107-111.
2. Brigadeau F, Kouakam C, Klug D, Marquie C, Duhamel A, Mizon-Gerard F, Lacroix D, Kacet S. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-707.
3. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-1915.
4. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Europace 2000;2:263-269.
5. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP. AVID Investigators. Antiarrhythmics versus Implantable Defibrillators. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001;103:2066-2071.
6. Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P, Dorian P. Electrical storm in patients with an implantable defibrillator: incidence features preventive therapy: insights from a randomized trial. Eur Heart J 2006;27:3027-3032. First published on October 18, 2006, doi:10.1093/eurheartj/ ehl276.
7. Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tatla DS, Brachmann J, Myerburg RJ, Cannom DS, van der Laan M, Holroyde MJ, Singer I, Pratt CM; SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646-3654.
8. Mazur A, Anderson ME, Bonney S, Roden DM. Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation. J Am Coll Cardiol 2001;37:1100-1105.
9. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus betablockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165-171.
10. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999;340:1855-1862.